Literature DB >> 10720644

Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle.

T Zheng1, W Li, J Wang, B T Altura, B M Altura.   

Abstract

The sphingomyelin pathway is now recognized as an important signal transduction system regulating various cellular functions, in which activation of a neutral sphingomyelinase induced by various extracellular stimulants results in selective degradation of sphingomyelin, yielding bioactive lipid intermediates, ceramides and phosphorylcholine. In the present study, our emphasis has been to examine the effects of exogenous Mg(2+)-dependent neutral sphingomyelinase, in physiological and pathophysiological magnesium concentrations, on phenylephrine-induced vasomotor tone and on intracellular free Ca(2+)([Ca(2+)](i)) mobilization in vitro. Neutral sphingomyelinase (0.001-0.1 U/ml), alone, did not elicit any significant changes in either basal tension or resting levels of [Ca(2+)](i) in rat aortic smooth muscle; similar results were obtained with phosphorylcholine. However, neutral sphingomyelinase (0.001-0.1 U/ml) and C(2)-ceramide or ceramide-1-phosphate, but not phosphorylcholine, attenuated phenylephrine-induced contractions, in isolated rat aortic rings, in a concentration-related manner. The addition of extracellular magnesium in different concentrations (0, 0.3, 1.2, 2.4 mM) modulated the neutral sphingomyelinase-vasorelaxant action in a concentration-dependent manner. Neutral sphingomyelinase-evoked relaxation was only partially endothelium-dependent. Nitric oxide synthase inhibitors, N(G)-nitro-L-arginine (L-NNA) and L-N(G)-monomethyl-arginine (L-NMMA), an inhibitor of prostanoid synthesis (indomethacin), and pharmacologic amine antagonists, such as atropine, diphenhydramine, cimetidine, propranolol, and methysergide as well as an opiate antagonist, naloxone, all failed to attenuate or interfere with the vasorelaxant responses of neutral sphingomyelinase. Three different inhibitors of protein kinase C (i.e., staurosporine, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7) or bisindolylmaleimide I), when used over a wide concentration range, also failed to interfere with the neutral sphingomyelinase-induced relaxations. Neutral sphingomyelinase inhibited the elevations in [Ca(2+)](i) in cultured rat aortic smooth muscle cells caused by phenylephrine. Our results suggest that a Mg(2+)-dependent sphingomyelin signaling pathway may play an important regulatory role in arterial wall tone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720644     DOI: 10.1016/s0014-2999(00)00045-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Ceramide 1-phosphate increases intracellular free calcium concentrations in thyroid FRTL-5 cells: evidence for an effect mediated by inositol 1,4,5-trisphosphate and intracellular sphingosine 1-phosphate.

Authors:  Susanna Högback; Petra Leppimäki; Britt Rudnäs; Sonja Björklund; J Peter Slotte; Kid Törnquist
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 2.  Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.

Authors:  Denise G Hemmings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04       Impact factor: 3.000

3.  Short-term Mg deficiency upregulates protein kinase C isoforms in cardiovascular tissues and cells; relation to NF-kB, cytokines, ceramide salvage sphingolipid pathway and PKC-zeta: hypothesis and review.

Authors:  Burton M Altura; Nilank C Shah; Gatha J Shah; Aimin Zhang; Wenyan Li; Tao Zheng; Jose Luis Perez-Albela; Bella T Altura
Journal:  Int J Clin Exp Med       Date:  2014-01-15

4.  Sphingolipids regulate [Mg2+]o uptake and [Mg2+]i content in vascular smooth muscle cells: potential mechanisms and importance to membrane transport of Mg2+.

Authors:  Tao Zheng; Wenyan Li; Bella T Altura; Nilank C Shah; Burton M Altura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-26       Impact factor: 4.733

5.  Metabolic formation of ceramide-1-phosphate in cerebellar granule cells: evidence for the phosphorylation of ceramide by different metabolic pathways.

Authors:  Laura Riboni; Rosaria Bassi; Viviana Anelli; Paola Viani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

6.  Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.

Authors:  Fiona A Mathieson; Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  Ceramide 1-phosphate enhances calcium entry through voltage-operated calcium channels by a protein kinase C-dependent mechanism in GH4C1 rat pituitary cells.

Authors:  Kid Törnquist; Tomas Blom; Ramin Shariatmadari; Michael Pasternack
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

8.  Magnesium deficiency upregulates sphingomyelinases in cardiovascular tissues and cells: cross-talk among proto-oncogenes, Mg(2+), NF-κB and ceramide and their potential relationships to resistant hypertension, atherogenesis and cardiac failure.

Authors:  Burton M Altura; Nilank C Shah; Gatha J Shah; Wenyan Li; Aimin Zhang; Tao Zheng; Zhiqiang Li; Xian-Cheng Jiang; Jose Luis Perez-Albela; Bella T Altura
Journal:  Int J Clin Exp Med       Date:  2013-10-25

9.  Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle.

Authors:  Jennifer S Moylan; Jeffrey D Smith; Erin M Wolf Horrell; Julie B McLean; Gergana M Deevska; Mark R Bonnell; Mariana N Nikolova-Karakashian; Michael B Reid
Journal:  Redox Biol       Date:  2014-07-30       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.